iPS Academia Japan, Inc.

Sharing the fruits of iPS cell research
for the good of all humanity

Japanese

What's New

What’s New


Other 2018/01/17

Updated the “Patent Information”

New patent information relates to iPS cell technologies for the month of December 2017 has been updated.
Please see Patent Information for more details.
We have updated the page once a month.

License-Out 2018/01/12

License Agreement Has Been Entered between iPS Academia Japan, Inc. and myriamed GmbH

iPS Academia Japan, Inc.:

We executed a non-exclusive license agreement with myriamed GmbH, Germany which provides services in drug development using iPS cell-derived cells, on the patents related to the iPS cell technology that have been sublicensed to us by Kyoto University.

myriamed GmbH:

We are excited about the execution of a license agreement with iPS Academia Japan, Inc., and look forward to merging the exciting reprogramming technology originally developed by Nobel laureate Prof. Shinya Yamanaka with our proprietary phenotypic heart muscle screening platform.

myriamed GmbH

License-Out 2018/01/05

License Agreement Has Been Entered with Bayer AG

We executed a non-exclusive license agreement for internal research with Bayer AG on the patents related to iPS cells technology which we have been granted a sublicensing right from Kyoto University.

Bayer AG

Other 2017/12/28

Updated the “Patent Information”

New patent information relates to iPS cell technologies for the month of November 2017 has been updated.
Please see Patent Information for more details.
We have updated the page once a month.

Other 2017/12/28

Our Office Closed Dec. 29 – Jan 3

Our office will be closed for winter holidays from Friday 29th December 2017 to Wednesday 3rd January 2018.
Please understand that our earliest replay to any inquiries received during the above period will be made on or after Thursday 4th January 2018.

We apologize for your inconvenience this may cause you during this period.

License-Out 2017/12/06

License Agreement Has Been Entered with Coyne Scientific, LLC

We executed a non-exclusive license agreement with Coyne Scientific, LLC which provides products and services related to iPS cells and iPS cell derived cells for research use, on the patents related to iPS cells technology which we have been granted a sublicensing right from Kyoto University.

Coyne Scientific, LLC

License-In 2017/11/29

Summary of 1 newly published patent application is added to “Patent Portfolio”

We released the summary of 1 newly published patent application from our “Patent Portfolio” as follows.

AJ134  Therapeutic or prophylactic composition for TDP-43 proteinopathy

Please find the detail from the link above.

*We are not disclosing any summaries of unpublished patent applications. After their publication, we announce on “What’s New”, and release on “Patent Portfolio.”

Other 2017/11/17

Updated the “Patent Information”

New patent information relates to iPS cell technologies for the month of October 2017 has been updated.
Please see Patent Information for more details.
We have updated the page once a month.

Exhibition 2017/11/09

BIO-Europe2017 in Germany

We presented our exhibition in BIO-Europe2017 in Berlin, Germany from November 6th (Mon.) till November 8th (Fri.), 2017. We very much appreciate many meetings in Berlin regarding our possible collaborations.

BioEurope-2017-01[1]  BioEurope-2017-02[1]

Other 2017/10/24

Updated the “Patent Information”

New patent information relates to iPS cell technologies for the month of September 2017 has been updated.
Please see Patent Information for more details.
We have updated the page once a month.

1 / 912345...Last »